Evidence map›Paper›PMID 25041866›Full record

ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2015

Relationship between glycemic control and gastric emptying in poorly controlled type 2 diabetes.

Adil E Bharucha, Yogish Kudva, Ananda Basu, Michael Camilleri, Phillip A Low, Adrian Vella, Alan R Zinsmeister

Open access · bronzeAbstract read
In one paragraph

Article in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Utility of aNeurogastroenterology and motility · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Electroceuticals: Unlocking the promise of therapies.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2024
    Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Adil E BharuchaClinical and Enteric Neuroscience Translational and Epidemiological Research Program, Division of Gastroenterology, Mayo Clinic, Rochester, Minnesota. Electronic address: bharucha.adil@mayo.edu.
Yogish KudvaDivision of Endocrinology, Mayo Clinic, Rochester, Minnesota.
Ananda BasuDivision of Endocrinology, Mayo Clinic, Rochester, Minnesota.
Michael CamilleriClinical and Enteric Neuroscience Translational and Epidemiological Research Program, Division of Gastroenterology, Mayo Clinic, Rochester, Minnesota.
Phillip A LowDepartment of Neurology, Mayo Clinic, Rochester, Minnesota.
Adrian VellaDivision of Endocrinology, Mayo Clinic, Rochester, Minnesota.
Alan R ZinsmeisterDivision of Biostatistics, Mayo Clinic, Rochester, Minnesota.
Mayo Clinic · US

Funding

Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
Physiological Characterization and Data Integration CoreP01DK068055 · NIDDK · MAYO CLINIC ROCHESTER · PI FARRUGIA, GIANRICO · 2004 to 2019
$23.8M
Obesity and Energy Metabolism CoreP30DK050456 · NIDDK · UNIVERSITY OF MINNESOTA TWIN CITIES · PI CROW, SCOTT J · 1995 to 2015
$17.0M
Studies on Diagnosis, Pathophysiology, and Treatment of Autonomic Failure in MSAP01NS044233 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LOW, PHILLIP A · 2003 to 2014
$12.4M
Training CoreU54NS065736 · NINDS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI FREEMAN, ROY · 2009 to 2018
$11.6M
SYMPATHETIC REGULATION OF VENOUS FUNCTION IN ORTHOSTATIC INTOLERANCE AND AGINGP50NS032352 · NINDS · MAYO CLINIC ROCHESTER · PI LOW, PHILLIP A · 1996 to 2009
$11.4M
ELECTRODE ARRAYS BASED ON THIN FILM TECHNOLOGYN01NS032352 · NINDS · STANFORD UNIVERSITY · PI WHITE, ROBERT L · 1985 to 1985
–
ORTHOSTATIC INTOLERANCE IN AUTONOMIC NEUROPATHIES &POSTURAL TACHYCARDIA SYNDROMEP01NS032352 · NINDS · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI JOYNER, MICHAEL J · 1995 to 1995
–
NCATS NIH HHS UL1 TR000135NIDDK NIH HHS P01 DK068055NIDDK NIH HHS P30 DK050456NIDDK NIH HHS R01 DK068055NINDS NIH HHS N01 NS032352NINDS NIH HHS NS 32352NINDS NIH HHS NS 44233NINDS NIH HHS P01 NS044233NINDS NIH HHS U54 NS065736
6 · The paper itself

Abstract

BACKGROUND &

aimsAcute hyperglycemia delays gastric emptying in patients with diabetes. However, it is not clear whether improved control of glycemia affects gastric emptying in these patients. We investigated whether overnight and short-term (6 mo) improvements in control of glycemia affect gastric emptying.

methodsWe studied 30 patients with poorly controlled type 2 diabetes (level of glycosylated hemoglobin, >9%). We measured gastric emptying using the [(13)C]-Spirulina platensis breath test on the patients' first visit (visit 1), after overnight administration of insulin or saline, 1 week later (visit 2), and 6 months after intensive therapy for diabetes. We also measured fasting and postprandial plasma levels of C-peptide, glucagon-like peptide 1, and amylin, as well as autonomic functions.

resultsAt visit 1, gastric emptying was normal in 10 patients, delayed in 14, and accelerated in 6; 6 patients had gastrointestinal symptoms; vagal dysfunction was associated with delayed gastric emptying (P < .05). Higher fasting blood levels of glucose were associated with shorter half-times of gastric emptying (thalf) at visits 1 (r = -0.46; P = .01) and 2 (r = -0.43; P = .02). Although blood levels of glucose were lower after administration of insulin (132 ± 7 mg/dL) than saline (211 ± 15 mg/dL; P = .0002), gastric emptying thalf was not lower after administration of insulin, compared with saline. After 6 months of intensive therapy, levels of glycosylated hemoglobin decreased from 10.6% ± 0.3% to 9% ± 0.4% (P = .0003), but gastric emptying thalf did not change (92 ± 8 min before, 92 ± 7 min after). Gastric emptying did not correlate with plasma levels of glucagon-like peptide 1 and amylin.

conclusionsTwo-thirds of patients with poorly controlled type 2 diabetes have mostly asymptomatic yet abnormal gastric emptying. Higher fasting blood levels of glucose are associated with faster gastric emptying. Overnight and sustained (6 mo) improvements in glycemic control do not affect gastric emptying.

Indexed as

Gastric EmptyingBlood GlucoseBreath TestsC-PeptideDiabetes Mellitus, Type 2FemaleGlucagon-Like Peptide 1HumansIslet Amyloid PolypeptideMaleMiddle AgedBlood GlucoseC-PeptideGlucagon-Like Peptide 1Islet Amyloid PolypeptideAutonomicDiabetes MellitusDMGastroparesis

Identifiers

PMID25041866
PMCPMC4297596
OpenAlexW2105383203

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.